Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
<p dir="ltr">The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably th...
محفوظ في:
| المؤلف الرئيسي: | Zohaib Yousaf (9617058) (author) |
|---|---|
| مؤلفون آخرون: | Fateen Ata (12217764) (author), Riyadh Ali Mohammed Hammamy (17563143) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
حسب: Salma, Younes
منشور في: (2024) -
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
حسب: Farah M. Shurrab (16324961)
منشور في: (2022) -
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
حسب: Salma Younes (6424865)
منشور في: (2024) -
Acute myocarditis following administration of BNT162b2 vaccine
حسب: Mhd Baraa Habib (11721774)
منشور في: (2021) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
حسب: Mohammad Altermanini (16810755)
منشور في: (2023)